Impact of mTOR expression on clinical outcome in paediatric patients with B-cell acute lymphoblastic leukaemia – preliminary report

@inproceedings{Uliska2016ImpactOM,
  title={Impact of mTOR expression on clinical outcome in paediatric patients with B-cell acute lymphoblastic leukaemia – preliminary report},
  author={Edyta Ulińska and Katarzyna Mycko and Elżbieta Sałacińska-Łoś and Agata Pastorczak and Alicja Siwicka and Wojciech M Młynarski and Michał Matysiak},
  booktitle={Contemporary oncology},
  year={2016}
}
AIM OF THE STUDY To characterise expression of mTOR (mammalian target of rapamycin) in childhood B-cell acute lymphoblastic leukaemia (ALL), and to evaluate a possible link between mTOR and clinical characteristics. MATERIAL AND METHODS The examined group consisted of 21 consecutive patients, aged 1-18 years, diagnosed with B-cell ALL in 2010, and 10 relapsed B-cell ALL patients diagnosed for the first time between 2009 and 2011, who developed relapse before 2014. All subjects were treated in… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 17 references

The mTOR Signalling Pathway in Human Cancer

International journal of molecular sciences • 2012
View 8 Excerpts
Highly Influenced

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.

Trends in biochemical sciences • 2011
View 4 Excerpts
Highly Influenced

Upstream and downstream of mTOR.

Genes & development • 2004
View 9 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…